Back to top
Live:
Coronavirus Updates

A new potential vaccine for SARS-CoV-2, the novel coronavirus that causes the COVID-19 disease, has been developed by scientists at the University of Pittsburgh School of Medicine, according to a press release from the University of Pittsburgh.

A peer-reviewed study on the vaccine was published in eBioMedicine.

The vaccine, which is called PittCoVacc (short for Pittsburgh CoronaVirus Vaccine), would work the same way as the seasonal flu shot, but with a high-tech delivery. It uses strands of viral protein made in the lab to build up immunity — which is how the flu shot vaccine works — but instead of injecting them via one needle, it delivers them through a fingertip-sized patch that has 400 microneedles made of sugar and the protein pieces. With this unique design, the tiny needles would dissolve into the person's skin.

According to the study's authors, the patch increases the potency of the protein pieces and gets them right into the skin, where the immune response is said to be the strongest. The method is relatively painless, according to Louis Falo, one of the study's co-senior authors. The patch is applied like an adhesive bandage, and in the press release Falo said it feels "kind of like Velcro."

When tested in mice, the researchers discovered that the vaccine generated a surge of antibodies, an immune response that neutralizes the virus, within two weeks of getting the vaccine.

The swift creation of this potential vaccine came from the team's past research on other coronaviruses.

"We had previous experience on SARS-CoV in 2003 and MERS-CoV in 2014," co-senior author Andrea Gambotto said in the press release about the project. "These two viruses, which are closely related to SARS-CoV-2, teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus. We knew exactly where to fight this new virus."

As a result, the research team was able to identify this particular protein quickly.

The University of Pittsburgh's press release said the vaccine is "highly scalable," an encouraging factor for a potential vaccine because of the pandemic's current magnitude and swift progression.

The study's authors hope to start a phase I human clinical trial in the coming months if they receive approval from the U.S. Food and Drug Administration.

Read the full press release.

In our latest HealthDay Now, Mabel Jong spoke with Dr. Lori Pierce, president of the American Society of Clinical Oncology and a cancer radiation specialist at the University of Michigan.

Dr. Pierce shared important takeaways from the recently concluded 2021 ASCO annual meeting and discussed why equity was the chosen theme this year.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HD Live! Videos

Watch our latest HealthDay Now as we cover the latest on the Johnson & Johnson COVID-19 vaccine investigation. An independent advisory panel to the CDC is waiting on additional information before making recommendations on the use of the Johnson & Johnson COVID-19 vaccine after reports about rare blood clots.

Mabel Jong from our liveblog team speaks with Lynn Bahta, a member of the CDC's Advisory Committee on Immunization Practices (ACIP) and a clinical expert for vaccines at the Minnesota Department of Health.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

Watch our latest HealthDay Now as we recap the highlights of the American Association for Cancer Research (AACR) Annual Meeting 2021.

Mabel Jong from our liveblog team speaks with Dr. Antoni Ribas, former president of the American Association for Cancer Research and professor of medicine at UCLA, and Anna Plym, PhD, a postdoctoral research fellow at Brigham and Women's Hospital.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

Watch our latest HealthDay Now as we dive into the latest details on multisystem inflammatory syndrome in children (MIS-C).

Mabel Jong from our liveblog team speaks with Dr. Mary Beth Son, Program Director of Boston Children's Hospital's Rheumatology Program, and Brian Padla, father of James Padla, who has MIS-C.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.


Watch our latest HealthDay Now as we debunk myths about the COVID-19 vaccines and talk about what the new CDC guidelines for vaccinated people mean.

Mabel Jong from our liveblog team speaks with Dr. Paul Offit, Director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia and one of the physicians on the FDA Vaccines and Related Biological Products Advisory Committee, and Dr. Mercedes Carnethon, Vice Chair of Preventive Medicine at the Northwestern Feinberg School of Medicine.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

Watch our latest HealthDay Now as we take a look at how living through the COVID-19 pandemic impacts children socially, mentally and emotionally.

One year in, this is their "new normal," but what does that mean for them? From social isolation to remote learning to a loss of structure and normalcy, we discuss how living during the pandemic has both short- and long-term effects on children.

Mabel Jong from our liveblog team speaks with:

  • Dr. Mark Reinecke, Department of Psychiatry & Behavioral Sciences, Northwestern University
  • Tracy Compton, a parent
  • Stephen Guerriero, a teacher
  • Jake Anderson, a student

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a look at the COVID-19 pandemic and the vaccination rollout and how they've impacted people of color.

Mabel Jong from our liveblog team speaks with:

  • Tasha Clark-Amar, CEO, East Baton Rouge Council on Aging
  • Jill Ramirez, Executive Director, Latino HealthCare Forum (Austin)
  • Vickie Mays, PhD, Professor, UCLA Fielding School of Public Health

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a look at the global COVID-19 vaccination rollout and how the United States rollout compares.

Mabel Jong from our liveblog team speaks with Dr. Ran Balicer of Clalit Health Services and Dr. Arnold Monto of University of Michigan School of Public Health.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

UPDATE 1/26/21: Since our HD Live! interview with CEO Andrei Doroshin, the Philadelphia Health Department has severed its ties with the organization. The nonprofit has changed its status to a for-profit entity.

Watch our latest HD Live! as we take a look at Philly Fighting Covid, a nonprofit organization run by graduate students from Drexel University that aims to help with mass COVID-19 vaccination in Philadelphia.

Mabel Jong from our liveblog team speaks with Andrei Doroshin, founder of Philly Fighting Covid.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.